Cholesterol
FDA Extends Approval for Alirocumab to Lower LDL-C in Pediatric Patients with HeFHÂ
Addressing an Unmet Need in Pediatric Patients with HeFHÂ Heterozygous
April 19, 2024
Addressing an Unmet Need in Pediatric Patients with HeFHÂ Heterozygous
Genetic testing is a cornerstone of personalized medicine. While it
This blog was written by Mackenzie Ames for Family Heart
During a recent virtual webinar, Cardiometabolic Health Congress faculty member
Genetic testing is a cornerstone of personalized medicine. While it
Genetic testing is a cornerstone of personalized medicine. While it
Officially launched in January 2014 by the FH Foundation, FIND
Familial hypercholesterolemia (FH) affects up to 1.3 million people in
View a Clinical Snapshot from Dr. Pamela Morris on the
One Minute, One Family It takes just 1 minute to
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
